摘要
[摘要 ]目的 探讨血栓通联合低分子肝素钙在治疗短暂性脑缺血发作中的效果。方法 选取 2018年 3月～ 2019年 2月我院收治的 45例短暂性脑缺血发作患者临床资料，依据治疗措施不同进行分组，对照组 15例和联合治疗组 30例，观察两组短暂性脑缺血发作患者治疗前后活化凝血活酶时间（ ATPP）、血小板计数（ PLT）、凝血酶原时间（ PT）、临床治疗总有效率情况。结果 两组短暂性脑缺血发作患者治疗前 ATPP、 PLT、 PT均无明显差异（ P>0.05），对照组治疗前后 ATPP、 PLT、 PT均无明显差异（ P>0.05），观察组治疗后 ATPP、 PT均高于治疗前， PLT均低于治疗前，观察组治疗后 ATPP、 PT均高于对照组， PLT均低于对照组，观察组短暂性脑缺血发作患者临床治疗总有效率均高于对照组，差异均有统计学意义（ P<0.05）。结论 血栓通联合低分子肝素钙在治疗短暂性脑缺血发作，临床效果明显，预后良好，值得临床推广应用。
[关键词 ]血栓通；低分子肝素钙；短暂性脑缺血发作；效果
[Abstract] Objective To explore the effect of Xueshuantong combined with low molecular weight heparin calcium in the treatment of transient ischemic attack. Methods the clinical data of 45 patients with TIA from March 2018 to February 2019 were selected and divided into two groups according to different treatment measures. 15 patients in the control group and 30 patients in the combined treatment group were observed before and after the treatment. The activated thromboplastin time (atpp), platelet count (PLT), prothrombin time (PT) and clinical treatment of the two groups were always Efficiency. Results there was no significant difference in atpp, PLT and Pt between the two groups before and after treatment (P > 0.05). There was no significant difference in atpp, PLT and Pt between the two groups before and after treatment (P > 0.05). After treatment, atpp and Pt in the observation group were higher than before treatment, PLT were lower than before treatment. After treatment, atpp and Pt in the observation group were higher than those in the control group, PLT were lower than those in the observation group The difference was statistically significant (P < 0.05). Conclusion Xueshuantong combined with low molecular weight heparin calcium in the treatment of transient ischemic attack, the clinical effect is obvious, the prognosis is good, it is worth clinical application.
出版日期
2020年04月27日（中国期刊网平台首次上网日期，不代表论文的发表时间）
